We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 08, 2021

Decreased Enrollment of Metastatic Invasive Lobar Carcinoma Subtype in Breast Cancer Trials

NPJ breast cancer


Additional Info

NPJ breast cancer
Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
NPJ Breast Cancer 2021 Oct 25;[EPub Ahead of Print], MK Abel, ME Melisko, HS Rugo, AJ Chien, I Diaz, JK Levine, A Griffin, J McGuire, LJ Esserman, HT Borno, RA Mukhtar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading